Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
about
Hyperglycemia Aggravates Cerebral Vasospasm after Subarachnoid Hemorrhage in a Rat Model.Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.Estradiol reduces ferrous citrate complex-induced NOS2 up-regulation in cerebral endothelial cells by interfering the nuclear factor kappa B transactivation through an estrogen receptor β-mediated pathwayRole of CT perfusion imaging in the diagnosis and treatment of vasospasm.Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhageL-arginine and nitric oxide in CNS function and neurodegenerative diseases.The Role of Nitric Oxide and Sympathetic Control in Cerebral Autoregulation in the Setting of Subarachnoid Hemorrhage and Traumatic Brain Injury.Lipid-based carriers for controlled delivery of nitric oxide.Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin.Nitric oxide inhalation reduces brain damage, prevents mortality, and improves neurological outcome after subarachnoid hemorrhage by resolving early pial microvasospasms.Baicalin Attenuates Subarachnoid Hemorrhagic Brain Injury by Modulating Blood-Brain Barrier Disruption, Inflammation, and Oxidative Damage in Mice.Age-dependent effect of treadmill exercise on hemorrhage-induced neuronal cell death in rats.Ferrous citrate up-regulates the NOS2 through nuclear translocation of NFκB induced by free radicals generation in mouse cerebral endothelial cells.Nebivolol attenuates cerebral vasospasm both by increasing endothelial nitric oxide and by decreasing oxidative stress in an experimental subarachnoid haemorrhage.Unusual cause of cerebral vasospasm after pituitary surgery.
P2860
Q30252715-AEDBBBB6-FBAF-4974-91F2-ABB4223B1EF4Q30445314-04E618F3-7276-4A92-885B-230D8DF4C248Q35078365-2B5F0C3F-44AB-4275-B4A8-B0AEFBDB9242Q36076511-A4DCF18D-E488-47F7-9CB6-20834B4A8564Q37115346-55484D40-C0B4-41EB-99D2-A2B6C90E76B4Q38134415-16972C7C-EED3-412C-B3C2-AF54F76E4064Q38537075-110DDFA7-7647-4FAF-8B18-139CF1B6CB49Q39100762-DE110B0B-E408-499F-AAEA-DC47124E3B1AQ39624959-FD491614-B9CE-47BD-96FA-49639EB3308BQ41055782-189D1F40-0CA2-4D22-97D0-E8396817204EQ41620368-5B32EEA5-C42F-4E59-8255-A16FFF3BC9F6Q41858827-4A92B3B2-B7C7-44CB-A8EE-EAAE0E1F1FB6Q42558159-6E2826E9-1F8E-4C0D-8F89-3EF33FDEAAD2Q47818345-330CE143-EE47-4152-9F0A-D4255EE84503Q53246550-08265187-C39C-4B3C-8383-FECBDBA02E1E
P2860
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@ast
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@en
type
label
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@ast
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@en
prefLabel
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@ast
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@en
P2860
P1433
P1476
Nitric oxide in subarachnoid haemorrhage and its therapeutics implications.
@en
P2093
P2860
P2888
P304
605-13; discussion 613
P356
10.1007/S00701-005-0721-1
P577
2006-03-15T00:00:00Z